Four Asean nations among 38 to get Avigan drug from Japan for clinical trial


BANGKOK (The Nation/ANN): Japan is preparing to send Avigan, a drug used for treating influenza, to 38 countries this week, with four Asean countries -- the Philippines, Malaysia, Indonesia and Myanmar -- joining the trial for Covid-19 patients.

Japan's Minister for Foreign Affairs Toshimitsu Motegi said that Avigan, also known as Favipiravir, would be dispatched this week free of charge to be used in experiments to treat patients with Covid-19.

Subscribe or renew your subscriptions to win prizes worth up to RM68,000!

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Asean , Avigan , Japan , clinical , trials , free , drug , Favipiravir

   

Next In Regional

Acting legend Tony Leung, Nvidia chief Huang get honorary doctorates from HK uni
India reports 'good progress' in Asean-India trade pact review talks
KL in 50th spot as London crowned world's best city for 10th consecutive year
Malaysia commends Laos for successful Asean 2024 chairmanship
Supply chain snags: Airlines in Malaysia, Thailand among those affected as travel demand rebounds
41 passengers injured as Hong Kong ferry bumps into pier on Central’s waterfront
DPM Zahid emphasises shared goals in meeting with Philippines President Marcos
Malaysia’s strategies as Asean chair in 2025 focus on regional value chains, says Anwar
Asean Foreign Ministers' meeting kicks off in Laos ahead of 44th and 45th Asean Summits
Asean must remain neutral to boost regional investment, says Tengku Zafrul

Others Also Read